Osteonecrosis of the jaw (ONJ) in cancer patients (PTS) with bone metastases treated with zoledronic acid: Update on prevention

被引：0
|
作者：
Vormola, Roberto [1 ]
Ortega, Cinzia [1 ]
Montemurro, Filippo [1 ]
Faggiuolo, Roberto
Bucci, Rosa Anna [1 ]
Nanni, Daniela
Goia, Franco
Aglietta, Massimo [1 ]
机构：
[1] Univ Div Med Oncol & Haematol, Inst Canc Res & Treatment, Candiolo, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Osteonecrosis of the jaw in cancer patients with bone metastases treated with zoledronic acid: The focus is prevention
    Vormola, R.
    Ortega, C.
    Montemurro, F.
    Faggiuolo, R.
    Nanni, D.
    Goia, F.
    Aglietta, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI72 - XI72
  • [2] Osteonecrosis of the jaw (ONJ) in prostate cancer patients with bone metastases treated with zoledronic acid (Z): A retrospective study
    Ortega, C.
    Montemurro, F.
    Faggiuolo, R.
    Vormola, R.
    Nanni, D.
    Goia, F.
    Gilardino, M. O.
    Aglietta, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI67 - XI68
  • [3] An effective program of prevention of osteonecrosis of the jaw (ONJ) in cancer patients (PTS) treated with bisphosphonates (B)
    La Verde, Nicla
    Borgonovo, Karen
    Sburlati, Paola
    Garassino, Marina Chiara
    Bianchi, Celso
    Mantica, Cristina
    Perrone, Silvia
    Pedretti, Donata
    Dimaiuta, Mariastella
    Farina, Gabriella
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 194 - 194
  • [4] Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer
    Van Poznak, Catherine H.
    Unger, Joseph M.
    Darke, Amy K.
    Moinpour, Carol
    Bagramian, Robert A.
    Schubert, Mark M.
    Hansen, Lisa Kathryn
    Floyd, Justin D.
    Dakhil, Shaker R.
    Lew, Danika L.
    Wade, James Lloyd, III
    Fisch, Michael J.
    Henry, N. Lynn
    Hershman, Dawn L.
    Gralow, Julie
    [J]. JAMA ONCOLOGY, 2021, 7 (02) : 246 - 254
  • [5] Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment
    Fusco, Vittorio
    Loidoris, Anastasios
    Colella, Giuseppe
    Vescovi, Paolo
    Campisi, Giuseppina
    [J]. BREAST, 2010, 19 (05): : 432 - 433
  • [6] Incidence of osteonecrosis of the jaw (ONJ) in metastatic renal cell cancer patients (mRCC) treated with zoledronic acid (ZA)
    Gyergyay, Fruzsina
    Nagyivanyi, Krisztian
    Biro, Krisztina
    Kuronya, Zsofia
    Nemeth, Hajnalka
    Geczi, Lajos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Prevention of Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates
    De Iuliis, Francesca
    Taglieri, Ludovica
    Amoroso, Lucrezia
    Vendittozzi, Stefania
    Blasi, Luciana
    Salerno, Gerardo
    Lanza, Rosina
    Scarpa, Susanna
    [J]. ANTICANCER RESEARCH, 2014, 34 (05) : 2477 - 2480
  • [8] Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions
    Fusco, Vittorio
    Rossi, Maura
    De Martino, Iolanda
    Alessio, Manuela
    Fasciolo, Antonella
    Numico, Gianmauro
    [J]. ACTA CLINICA BELGICA, 2018, 73 (02) : 163 - 164
  • [9] Osteonecrosis of the jaw (ONJ) in patients (PTS) treated with bisphosphonates (BP): A regional experience
    Fusco, V.
    Vandone, A.
    Vormola, R.
    Gorzegno, G.
    Miraglia, S.
    Ciuffreda, L.
    Ortega, C.
    Baraldi, A.
    Siffredi, G.
    Bertetto, O.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 59 - 59
  • [10] Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab
    Fusco, Vittorio
    Bedogni, Alberto
    Campisi, Giuseppina
    [J]. SUPPORTIVE CARE IN CANCER, 2014, 22 (07) : 1737 - 1738
12345